Social Cognition in Youth Who Have a First Degree Relative With Schizophrenia
1 other identifier
interventional
82
1 country
1
Brief Summary
Social cognition is an individual's ability to perceive, process, understand, and react to other individuals in a social situation. Social cognition is impaired in individuals with schizophrenia, including difficulty recognizing others' emotions. A promising treatment avenue for emotion recognition problems in individuals with schizophrenia is continued practice with various facial expression recognition training programs. First degree relatives of someone with schizophrenia are considered at familial high risk (FHR) for the illness, because of its high level of heritability. It is therefore critical to explore if these emotion recognition training programs could also benefit people at FHR. In this current study, the investigators aim to explore the social-cognitive profiles and their neural correlates in FHR individuals. The investigators also aim to explore the potential efficacy of an emotion recognition intervention to improve this ability in FHR individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable schizophrenia
Started Jul 2021
Typical duration for not_applicable schizophrenia
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 18, 2020
CompletedFirst Posted
Study publicly available on registry
December 23, 2020
CompletedStudy Start
First participant enrolled
July 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 22, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 22, 2025
CompletedJanuary 2, 2026
December 1, 2025
4.1 years
December 18, 2020
December 29, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Change in emotion recognition performance from baseline - PENN Emotion Recognition Test
Penn Emotion Recognition test - tests the participant's ability to recognize emotion from facial expressions
baseline and post treatment (1 month)
Change in brain activity during emotion recognition tasks from baseline
Brain activity as measured using task-based functional magnetic resonance imaging (fMRI).
baseline and post treatment (1 month)
Study Arms (2)
Emotion Recognition Training
EXPERIMENTALControl Training
OTHERControl
Interventions
Participants will undergo 2 fMRI scans, one before and one after the training sessions. There will be 4 visits consisting of an emotion recognition training exercise on iPad, lasting for a period of \~1 hour each. (More details about each condition will be added after study completion to protect the blinding of participants) .
Participants will undergo 2 fMRI scans, one before and one after the training sessions. There will be 4 visits consisting of a control training exercise on iPad, lasting for a period of \~1 hour each. (More details about each condition will be added after study completion to protect the blinding of participants) .
Eligibility Criteria
You may qualify if:
- Between (or equal to) 15-35 years of age
- Ability to read/speak fluent English
- Diagnosis of SZ, schizoaffective disorder or schizophreniform confirmed for 1st degree relative by referring psychiatrist or two reliable informants (using the adapted FIGS questionnaire).
You may not qualify if:
- No diagnosis of psychosis related disorder
- Significant neurological or medical disorders that may produce cognitive impairment
- Current epilepsy or previous history of seizures
- Previous head injury with current continuing symptoms (i.e., cognitive ability, dizziness, etc.)
- Recent history of substance abuse or dependence (within past 3 months)
- MRI contraindication (e.g. metallic head implant, history of seizure, pacemaker, pregnancy, etc.)
- Current IQ \< 70 as measured by the Wechsler Abbreviated Scale of Intelligence Scale (WASI)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Royal Ottawa Mental Health Centre
Ottawa, Ontario, K1Z 7K4, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Due to the nature of the intervention, treatment administrators will not be able to remain blind to group assignment; however, assessment staff, investigators, and participants will be blind to group assignment. Assessment staff and investigators will never be involved in the randomization or treatment procedures.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 18, 2020
First Posted
December 23, 2020
Study Start
July 21, 2021
Primary Completion
August 22, 2025
Study Completion
August 22, 2025
Last Updated
January 2, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP, ANALYTIC CODE
- Time Frame
- De-identified data will become available upon completion of the study and once results have been published in an academic journal (anticipated time frame: the year of 2026).
De-identified data collected from this study may be shared with other researchers at the Royal's Institute of Mental Health Research for analyses and re-analyses. Variables of the study and scripts used for analyses will be made available to the public. De-identified data will also be shared with the general public upon request. Data that can connect with participants' identity will NOT be used or shared for analyses.